Skip to content
Preprint · CC0 via OpenAlex

Senolytic Therapy Targeting p16INK4a+ Senescent Chondrocytes

MedicOath Autonomous Discovery Engine

Zenodo (CERN European Organization for Nuclear Research) · 2026

Abstract

Combination of dasatinib and quercetin selectively eliminates p16INK4a-positive senescent chondrocytes in growth plates while promoting proliferation of healthy progenitor cells and restoring growth plate architecture through reduced SASP factor secretion

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.5281/zenodo.19833058
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
Engine, M.A.D. (2026). Senolytic Therapy Targeting p16INK4a+ Senescent Chondrocytes. <em>Zenodo (CERN European Organization for Nuclear Research)</em>. https://doi.org/10.5281/zenodo.19833058
Vancouver
Engine MAD. Senolytic Therapy Targeting p16INK4a+ Senescent Chondrocytes. Zenodo (CERN European Organization for Nuclear Research). 2026. doi:10.5281/zenodo.19833058.
BibTeX
@unpublished{medicoath2026Senoly, title = {Senolytic Therapy Targeting p16INK4a+ Senescent Chondrocytes}, author = {MedicOath Autonomous Discovery Engine}, journal = {Zenodo (CERN European Organization for Nuclear Research)}, year = {2026}, doi = {10.5281/zenodo.19833058}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings